pyrroles has been researched along with vx680 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atteridge, CE; Biggs, WH; Carter, TA; Edeen, PT; Fabian, MA; Floyd, M; Ford, JM; Grotzfeld, RM; Herrgard, S; Insko, DE; Lockhart, DJ; Mehta, SA; Milanov, ZV; Pao, W; Patel, HK; Sawyers, CL; Shah, NP; Treiber, DK; Varmus, H; Velasco, AM; Wodicka, LM; Zarrinkar, PP | 1 |
| Thomas, X | 1 |
| Abeltino, M; Bonati, A; Cantoni, AM; Corradi, A; Donofrio, G; Giuliani, N; Lombardi, G; Lunghi, P; Mazzera, L; Ricca, M | 1 |
| Hariki, S; Hongama, K; Katayama, K; Noguchi, K; Nonomiya, Y; Sugimoto, Y | 1 |
| Arang, N; Bello, T; Dudgeon, DR; Glennon, EK; Gujral, TS; Kain, HS; Kaushansky, A; Walter, ENF | 1 |
| Abeltino, M; Bonati, A; Cantoni, AM; Corradi, A; Lombardi, G; Lunghi, P; Mazzera, L; Naponelli, V; Perris, R; Ria, R; Ricca, M; Rizzi, FMA; Saltarella, I; Vacca, A | 1 |
1 review(s) available for pyrroles and vx680
| Article | Year |
|---|---|
[Acute lymphoblastic leukemia with Philadelphia chromosome: treatment with kinase inhibitors].
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Benzamides; Benzenesulfonates; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indoles; Niacinamide; Phenylurea Compounds; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Sunitinib; Thiazoles | 2007 |
5 other study(ies) available for pyrroles and vx680
| Article | Year |
|---|---|
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases.
Topics: Aminoquinolines; Aniline Compounds; Cell Line; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Indoles; Kinetics; Morpholines; Mutation; Naphthalenes; Neoplasms; Oncogene Proteins v-abl; Organic Chemicals; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles; Sunitinib | 2005 |
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL.
Topics: Aged; Aged, 80 and over; Animals; Apoptosis; Aurora Kinase A; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; I-kappa B Kinase; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Multiple Myeloma; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrroles; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2013 |
Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced Aneuploidy.
Topics: Anaphase; Aneuploidy; Aurora Kinase B; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Humans; MCF-7 Cells; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles | 2017 |
Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles.
Topics: Animals; Cell Line, Tumor; HEK293 Cells; Hepatocytes; Host-Parasite Interactions; Humans; Indoles; Liver; Malaria; Mice; Piperazines; Plasmodium yoelii; Protein Kinase Inhibitors; Protein Kinases; Purines; Pyrroles; RNA Interference; Roscovitine; Sporozoites; Sunitinib | 2017 |
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
Topics: Animals; Apoptosis; Aurora Kinase A; Aurora Kinase B; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; NF-kappa B; NF-kappaB-Inducing Kinase; Piperazines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrroles; STAT3 Transcription Factor; TNF Receptor-Associated Factor 2; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |